Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis

被引：0
|
作者：
Cindy L. J. Weinstein
Alan G. Meehan
Jianxin Lin
Steven D. Briscoe
Marinella Govoni
机构：
[1] Merck & Co.,
[2] Inc,undefined
[3] MSD Italy,undefined
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Golimumab; TNF-α; Treatment persistence; Rheumatoid arthritis; Psoriatic arthritis; Ankylosing spondylitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3397 / 3405
页数：8
相关论文
共 50 条
  • [41] Predictors of Treatment Retention Among Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Treated with Remicade® (Infliximab) for Long-Term in Canadian Real-World
    Starr, Michael
    Keystone, Edward
    Faraawi, Rafat
    Bessette, Louis
    Haraoui, Boulos
    Olszynski, Wojciech
    Kelsall, John
    Joshi, Raman
    Chow, Andrew
    Jovaisas, Algis
    Thorne, J. Carter
    Rampakakis, Emmanouil
    Psaradellis, Eliofotisti
    Marrache, Marilise
    Osborne, Brendan
    Maslova, Karina
    Nantel, Francois
    Lehman, Allen J.
    Tkaczyk, Cathy
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [42] Clinical Outcomes of Golimumab As Second Line TNF Inhibitor Treatment in Patients with Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) or Ankylosing Spondylitis (AS) - Subanalysis of a Non-Interventional Study in Germany
    Krueger, Klaus
    Burmester, Gerd R.
    Wassenberg, Siegfried
    Thiele, Astrid
    Thomas, Matthias H.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [43] Long-Term Treatment With Golimumab is a Safe Treatment Option Regardless of Risk Factors in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis: Results From a RealWorld Canadian Setting
    Arendse, Regan
    Rahman, Proton
    Bessette, Louis
    Baer, Philip
    Haaland, Derek
    Sholter, Dalton
    Rachich, Meagan
    Rampakakis, Emmanouil
    Vaillancourt, Julie
    Marrache, Marilise
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 63 - 63
  • [44] A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis
    Jessop, JD
    O'Sullivan, MM
    Lewis, PA
    Williams, LA
    Camilleri, JP
    Plant, MJ
    Coles, EC
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (09): : 992 - 1002
  • [45] Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
    Mease, P. J.
    Ory, P.
    Sharp, J. T.
    Ritchlin, C. T.
    Van den Bosch, F.
    Wellborne, F.
    Birbara, C.
    Thomson, G. T. D.
    Perdok, R. J.
    Medich, J.
    Wong, R. L.
    Gladman, D. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 702 - 709
  • [46] Lack Of Correlation Between Golimumab Exposure and Selected Safety Events Following Intravenous Or Subcutaneous Administration In An Integrated Analysis Of Phase 3 Data Of Patients With Rheumatoid Arthritis, Psoriatic Arthritis, Or Ankylosing Spondylitis
    Leu, Jocelyn H.
    Beutler, Anna
    Mendelsohn, Alan M.
    Liao, Sam
    Davis, Hugh M.
    Zhou, Honghui
    Xu, Zhenhua
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S599 - S599
  • [47] High long-term retention rates of Secukinumab in psoriatic arthritis and ankylosing spondylitis: a 3-year interim analysis from the observational, prospective SERENA study, in Greek patients
    Andreas Bounas
    Anna Kandyli
    Gkikas Katsifi
    Dimitrios Boumpa
    Maria G. Tektonidou
    Sousana Gazi
    Anastasios Kotrotsios
    Lazaros I. Sakkas
    Athanasios N. Georgiadis
    Loukas Settas
    Xenia Madia
    Dimitra Ignatiadi
    Petros P. Sfikakis
    Rheumatology International, 45 (5)
  • [48] Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
    A. Deodhar
    P. J. Mease
    I. B. McInnes
    X. Baraliakos
    K. Reich
    A. Blauvelt
    C. Leonardi
    B. Porter
    A. Das Gupta
    A. Widmer
    L. Pricop
    T. Fox
    Arthritis Research & Therapy, 21
  • [49] Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
    Deodhar, A.
    Mease, P. J.
    McInnes, I. B.
    Baraliakos, X.
    Reich, K.
    Blauvelt, A.
    Leonardi, C.
    Porter, B.
    Gupta, A. Das
    Widmer, A.
    Pricop, L.
    Fox, T.
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [50] Two-year clinical outcomes after discontinuation of long-term golimumab therapy in Korean patients with rheumatoid arthritis
    Shin, Kichul
    Kwon, Hyun Mi
    Kim, Min Jung
    Yoon, Myung Jae
    Chai, Hyun Gyung
    Kang, Seong-Wook
    Park, Won
    Park, Sung-Hwan
    Suh, Chang Hee
    Kim, Hyun Ah
    Lee, Seung-Geun
    Lee, Choong Ki
    Bae, Sang-Cheol
    Park, Yong-Beom
    Song, Yeong Wook
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (05): : 1061 - +
12345